Publikationen in Zusammenarbeit mit Forschern von Hospital Xeral Calde (32)

2013

  1. A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75

  2. Evidence of association of the NLRP1 gene with giant cell arteritis

    Annals of the Rheumatic Diseases

  3. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886

2012

  1. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population

    Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70

  2. Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis

    Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279

2011

  1. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601

  2. Analysis of the rel polymorphism rs13031237 in autoimmune diseases

    Annals of the Rheumatic Diseases

  3. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 1 SUPPL. 64

  4. The functional polymorphism 844 A>G in Fc αRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility

    Journal of Rheumatology, Vol. 38, Núm. 3, pp. 446-449

2010

  1. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 4, pp. 700-705

  2. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European study (EUSTAR)

    Journal of Rheumatology, Vol. 37, Núm. 8, pp. 1673-1679

  3. Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 10, pp. 2076-2080

  4. Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 11, pp. 2331-2333

  5. Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 1, pp. 131-135

  6. Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1502-1504

  7. Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis

    Human Immunology, Vol. 71, Núm. 5, pp. 525-529

2009

  1. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 10, pp. 1618-1620

  2. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus

    Human Molecular Genetics, Vol. 18, Núm. 19, pp. 3739-3748

  3. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

    Clinical and Experimental Rheumatology

  4. Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis

    Journal of Rheumatology, Vol. 36, Núm. 5, pp. 1021-1025